Houlihan Lokey, Inc.
NYSE:HLI
186.53 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,914.404 | 1,809.447 | 2,269.958 | 1,525.452 | 1,159.368 | 1,084.385 | 963.364 | 872.091 | 693.765 | 680.872 | 592.45 | 520.285 |
Cost of Revenue
| 1,213.589 | 1,147.879 | 1,408.634 | 971.195 | 737.762 | 692.073 | 636.631 | 582.244 | 461.609 | 475.1 | 414.918 | 0 |
Gross Profit
| 700.815 | 661.568 | 861.324 | 554.257 | 421.606 | 392.312 | 326.733 | 289.847 | 232.156 | 205.772 | 177.532 | 520.285 |
Gross Profit Ratio
| 0.366 | 0.366 | 0.379 | 0.363 | 0.364 | 0.362 | 0.339 | 0.332 | 0.335 | 0.302 | 0.3 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 185.324 | 142.903 | 150.275 | 95.56 | 93.301 | 795.119 | 64.158 | 57.795 | 63.163 | 56.194 | 53.169 | 0 |
Selling & Marketing Expenses
| 1,253.434 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 185.324 | 142.903 | 150.275 | 95.56 | 93.301 | 795.119 | 64.158 | 57.795 | 63.163 | 56.194 | 53.169 | 372.551 |
Other Expenses
| -1,486.773 | 176.927 | 98.185 | 50.54 | 98.704 | -27.436 | 3.39 | -3.508 | -0.77 | 18.897 | 2.478 | 0 |
Operating Expenses
| 1,486.773 | 319.83 | 248.46 | 146.1 | 192.005 | 865 | 112.287 | 107.852 | 103.218 | 75.091 | 74.684 | 423.811 |
Operating Income
| 399.095 | 341.738 | 612.864 | 408.157 | 229.601 | 224.32 | 214.446 | 181.995 | 126.4 | 128.654 | 102.848 | 95.393 |
Operating Income Ratio
| 0.208 | 0.189 | 0.27 | 0.268 | 0.198 | 0.207 | 0.223 | 0.209 | 0.182 | 0.189 | 0.174 | 0.183 |
Total Other Income Expenses Net
| -8.556 | -2.738 | -8.926 | 1.071 | 6.046 | 4.793 | 3.39 | -3.508 | -3.308 | -2.76 | 2.478 | 2.918 |
Income Before Tax
| 390.539 | 339 | 603.938 | 409.228 | 235.647 | 224.32 | 217.836 | 178.487 | 125.63 | 132.135 | 105.326 | 98.311 |
Income Before Tax Ratio
| 0.204 | 0.187 | 0.266 | 0.268 | 0.203 | 0.207 | 0.226 | 0.205 | 0.181 | 0.194 | 0.178 | 0.189 |
Income Tax Expense
| 110.238 | 69.777 | 165.614 | 96.457 | 51.854 | 65.214 | 45.553 | 70.144 | 55.863 | 52.196 | 43.898 | 39.381 |
Net Income
| 280.301 | 254.223 | 437.751 | 312.771 | 183.793 | 159.106 | 172.283 | 108.343 | 69.741 | 79.881 | 61.32 | 58.974 |
Net Income Ratio
| 0.146 | 0.14 | 0.193 | 0.205 | 0.159 | 0.147 | 0.179 | 0.124 | 0.101 | 0.117 | 0.104 | 0.113 |
EPS
| 4.36 | 4.01 | 6.74 | 4.75 | 2.96 | 2.42 | 2.6 | 1.77 | 1.18 | 1.32 | 1.01 | 100.32 |
EPS Diluted
| 4.11 | 3.76 | 6.41 | 4.55 | 2.8 | 2.42 | 2.6 | 1.63 | 1.1 | 1.32 | 1.01 | 100.32 |
EBITDA
| 427.631 | 399.959 | 661.401 | 423.385 | 246.892 | 238.795 | 222.351 | 190.848 | 138.975 | 138.216 | 108.888 | 2.962 |
EBITDA Ratio
| 0.223 | 0.221 | 0.291 | 0.278 | 0.213 | 0.22 | 0.231 | 0.219 | 0.2 | 0.203 | 0.184 | 0.006 |